Why Novo Nordisk A/S (NVO) Stock Rose 1.42% in 10 Minutes on Nov 13, 2026
The 1.42% gain was larger than any reaction MoveSurge measured after Novo Nordisk A/S headlines between Aug 15, 2026 and Nov 12, 2026; the largest of those was -0.40% in 10 minutes, on Nov 5, 2026.
- NVO rose 1.42% in the 10 minutes after the 12:16:00 ET headline, from $41.11 to $41.69.
- The first minute was nearly flat at +0.02%; the stock reached +1.42% at 10 minutes.
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +10m | +1m % | +10m % |
|---|---|---|---|---|---|---|
| NVO | 41.11 | 41.11 | 41.12 | 41.69 | +0.02% | +1.42% |
Novo Nordisk A/S (NVO) shares rose 1.42% in the 10 minutes after this headline reached the MoveSurge news feed at 12:16:00 ET on Friday, November 13, 2026: “Novo Nordisk wins EU approval to sell Frehemgo for routine prevention of bleeding episodes in patients with hemophilia A”
NVO in the first 10 minutes
From a reference price of $41.11 just before the headline, the stock was up 0.02% after one minute and up 1.42%, at $41.69, after 10 minutes. The first minute was nearly flat; the move came after it.
Earlier NVO headlines and the measured reaction
The 1.42% gain was larger than any reaction MoveSurge measured after Novo Nordisk A/S headlines between Aug 15, 2026 and Nov 12, 2026; the largest of those was -0.40% in 10 minutes, on Nov 5, 2026.
- Nov 5, 2026, 15:02 ET: “Korro Bio says Novo Nordisk terminated research collaboration and license agreement” (-0.40% in 10 minutes)
- Aug 19, 2026, 09:09 ET: “'Novo Nordisk Begins Testing Lower Doses of Wegovy Weight-Loss Pills' - WSJ” (+0.02% in 15 minutes)
Novo Nordisk A/S at a glance
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Market value | $180.04 billion (as of Nov 13, 2026) |
Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.
What headline moved Novo Nordisk A/S stock on November 13, 2026?
At 12:16:00 ET, this headline crossed: “Novo Nordisk wins EU approval to sell Frehemgo for routine prevention of bleeding episodes in patients with hemophilia A”. The stock rose 1.42% in the next 10 minutes.
How far did NVO move after the headline?
From $41.11 just before the headline to $41.69 10 minutes later, a +1.42% move.
What else has moved NVO stock recently?
The two largest measured reactions before November 13, 2026: Nov 5, 2026, Korro Bio says Novo Nordisk terminated research collaboration and license agreement (-0.40% in 10 minutes); Aug 19, 2026, 'Novo Nordisk Begins Testing Lower Doses of Wegovy Weight-Loss Pills' - WSJ (+0.02% in 15 minutes).
Sources
-
NVO headline and measured reaction, Nov 13, 2026
— MoveSurge
The headline as it crossed, its timestamp, and the measured price reaction reported on this page.
Never miss the next market-moving story
Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.
Go live — 7 days for $29 Watch live headlines -- free